EUVIMEDEUVIMED entdecken
Open Access

The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function

Karen Tsai iD, Huiyan Ma, Tom Z Liang, Yan Xing, Samuel Chung, Tanya Dorff, Diana Bell, Melissa G Lechner iD

Thyroid® · 2024

DOI: 10.1089/thy.2023.0542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, 2024. Verfasst von Karen Tsai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Metabolism, City of Hope Comprehensive Cancer Center, Duarte, California, USA. Hauptthemen laut MEDLINE: Hypothyroidism, Thyroid Diseases, Hyperthyroidism, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismThyroid DiseasesHyperthyroidismNeoplasmsHumansMiddle AgedImmune Checkpoint InhibitorsTyrosine Kinase InhibitorsThyroid Function TestsRetrospective StudiesThyrotropinThyroid Hormones

Stichwörter der Autor:innen

hyperthyroidismhypothyroidismimmune checkpoint inhibitorsurvivalthyroid dysfunctionthyroid function teststyrosine kinase inhibitor

Substanzen

Immune Checkpoint InhibitorsTyrosine Kinase InhibitorsThyrotropinThyroid Hormones

Autor:innen und Institutionen

  • Department of Diabetes, Endocrinology and Metabolism, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Division of Biostatistics, Department of Computational and Quantitative Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.
  • Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
  • Department of Medical Oncology, and City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Division of Endocrinology, UCLA Geffen School of Medicine, Los Angeles, California, USA.

ORCID-Profile: Karen Tsai, Melissa G Lechner

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Tsai, K., Ma, H., Liang, T. Z., Xing, Y., Chung, S., Dorff, T., Bell, D., & Lechner, M. G. (2024). The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function. Thyroid®. https://doi.org/10.1089/thy.2023.0542

Vancouver

Tsai K, Ma H, Liang TZ, Xing Y, Chung S, Dorff T, et al. The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function. Thyroid®. 2024. doi:10.1089/thy.2023.0542

BibTeX
@article{Tsai2024,
  author = {Tsai, Karen and Ma, Huiyan and Liang, Tom Z and Xing, Yan and Chung, Samuel and Dorff, Tanya and Bell, Diana and Lechner, Melissa G},
  title = {The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function},
  journal = {Thyroid®},
  year = {2024},
  doi = {10.1089/thy.2023.0542}
}
Kostenlos starten →